64X
Live / Applied — Statement of use — processing complete, to examiner (as of 02 Apr 2026)
What this means for you
Not registered yet, but its 23 Aug 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90898102
- Mark type
- Stylized text
- Filed
- 23 Aug 2021
- Published for opposition
- 24 Jan 2023
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 001 — Chemicals: Biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, biological organisms, and nucleic acids for scientific and research, biologics namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, biological organisms, and nucleic acids for industrial and manufacturing use; biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, and nucleic acids for use in medical research in the field of human and animal therapeutics
- Class 005 — Pharmaceuticals: Biologics, namely, cell lines, engineered cell lines, cell line components, cell culture media, viruses, biological organisms, and nucleic acids for use as therapeutics for clinical, medical and veterinary use
- Class 040 — Treatment of materials: Custom manufacturing of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; custom manufacturing of nucleic acids, biological organisms, cells, viruses and components and products thereof in the nature of therapeutics for scientific, engineering, research, agricultural, food, chemical, energy, industrial and manufacturing use
- Class 042 — Scientific and technological services: Scientific research and custom synthesis in the nature of scientific testing in the field of biologics; scientific research and development; pharmaceutical, medical, scientific, and biopharmaceutical research and development; custom cell-line engineering services; biochemical research and development services, namely, custom development and synthesis of nucleic acids, biological organisms, cells, cell line components, viruses and components and products thereof for scientific, engineering, research, agricultural, food, chemical, energy, industrial and manufacturing use; custom synthesis of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; bioinformatic design of genetically engineered organisms; research, design, and development of genetically engineered organisms; product development consultation in the fields of pharmaceutical, medical, scientific, and biopharmaceutical research and development; product development in the fields of products for scientific, engineering, research, agricultural, food, chemical, energy, industrial and manufacturing use
Owner
- 64-X, Inc., Brisbane, CA, US
- 64-X, Inc., San Francisco, CA, US
Prosecution history
- 02 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Mar 2026 — USE AMENDMENT FILED
- 23 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 05 Feb 2026 — SOU EXTENSION 5 GRANTED
- 16 Sept 2025 — SOU EXTENSION 5 FILED
- 05 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 11 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jun 2025 — SOU EXTENSION 4 GRANTED
- 21 Mar 2025 — SOU EXTENSION 4 FILED
- 21 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED